164 filings
8-K
TRIL
Trillium Therapeutics Inc.
17 Nov 21
Pfizer Completes Acquisition of Trillium Therapeutics
9:28am
8-K
TRIL
Trillium Therapeutics Inc.
16 Nov 21
Other Events
5:07pm
8-K
TRIL
Trillium Therapeutics Inc.
29 Oct 21
Trillium Therapeutics Receives Final Court Order Approving Arrangement
6:00am
8-K
TRIL
Trillium Therapeutics Inc.
27 Oct 21
Trillium Securityholders Approve Acquisition by Pfizer
6:00am
8-K
TRIL
Trillium Therapeutics Inc.
20 Oct 21
Other Events
6:03am
8-K
dqtw6lg e7
15 Oct 21
Other Events
6:00am
8-K
sbvqihm b6ov1nw
13 Oct 21
Other Events
8:05am
8-K
y5tljm 5gprjm
23 Aug 21
Voting Support Agreement
7:53am
8-K
iymnpkb3kvcc
13 Aug 21
Trillium Therapeutics Reports Second Quarter 2021 Operating and Financial Results
7:05am
8-K
4ch8 9yes5
30 Jun 21
Trillium Therapeutics Appoints Catherine Mackey, PH.D., to Its Board of Directors
7:00am
8-K
rnnx9qdm 4p3z1gt6
9 Jun 21
Trillium Announces Voting Results from the Annual General and Special Meeting of Shareholders
7:01am
8-K
gxw gy8ldk0j1g2d
7 May 21
Trillium Therapeutics Reports First Quarter 2021 Operating and Financial Results
7:02am
8-K
7ehgld
28 Apr 21
Results of Operations and Financial Condition
7:04am
8-K
q5a1va9 vx4y2lz
23 Apr 21
Results of Operations and Financial Condition
7:01am
8-K
rw37fc69yqdh
22 Apr 21
Regulation FD Disclosure
7:00am
8-K
8pa48 zjrxljt
18 Mar 21
Trillium Therapeutics Reports Annual Operating and Financial Results and Sets Date for R&D Day
4:05pm
6-K
hi5hlbr1r5nud23fen3
7 Dec 20
Trillium Therapeutics Presented Clinical Data at the 62ND Ash Annual Meeting and Provides Guidance for 2021
4:05pm
6-K
8dbrd xjz8rihmdazshb
25 Nov 20
Trillium Therapeutics to Present Clinical Data at the 62ND American Society of Hematology Annual Meeting
7:03am
6-K
prcqtoe3lh8vjmfl 3o
16 Nov 20
Consolidated Financial Statements
7:09am
6-K
dj4swh
12 Nov 20
Trillium Therapeutics Appoints Paolo Pucci
4:05pm